26-Dec-2025
Stocks make small moves post-Christmas, while precious metals hit new record highs
Seeking Alpha News (Fri, 26-Dec 10:33 AM ET)
ACA health insurance marketplace enrollment declines as subsidies set to expire
Seeking Alpha News (Tue, 23-Dec 12:17 PM ET)
Elevance Health Reflects On The Changed Role of Health Plans
Business Wire (Fri, 12-Dec 2:00 PM ET)
AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries
Business Wire (Fri, 12-Dec 11:10 AM ET)
Business Wire (Wed, 10-Dec 4:30 PM ET)
Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence
Business Wire (Fri, 5-Dec 2:00 PM ET)
Business Wire (Mon, 24-Nov 10:00 AM ET)
Elevance Health Grows Revenue 12%, Invests for Future While Managing Margin Pressures in Q3 2025
Market Chameleon (Tue, 21-Oct 3:07 AM ET)
Elevance Health Reports Third Quarter 2025 Results
Business Wire (Tue, 21-Oct 6:00 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of December 26, 2025, ELV stock price climbed to $349.88 with 595,245 million shares trading.
ELV has a beta of 0.24, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.02 to the broad based SPY ETF.
ELV has a market cap of $77.76 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $50 billion in Revenue and $6.03 earnings per share. This beat revenue expectation by $579 million and exceeded earnings estimates by $1.07.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has underperformed the market in the last year with a price return of -4.5% while the SPY ETF gained +16.0%. However, in the short term, ELV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.4% vs +4.6% return in SPY. But in the last 2 weeks, ELV shares have been beat by the market, returning -2.6% compared to an SPY return of +1.5%.
ELV support price is $336.75 and resistance is $349.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.